Twin Tree Management, LP Reata Pharmaceuticals Inc Transaction History

Twin Tree Management, LP

  • $50 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 12, 2020
SELL
$126.3 - $176.56 $1.32 Million - $1.84 Million
-10,433 Closed
0 $0
Q1 2020

May 13, 2020
BUY
$124.16 - $247.74 $1.3 Million - $2.58 Million
10,433 New
10,433 $1.51 Million
Q2 2019

Aug 12, 2019
SELL
$77.72 - $94.35 $6,994 - $8,491
-90 Closed
0 $0
Q1 2019

May 10, 2019
BUY
$51.9 - $101.79 $4,671 - $9,161
90 New
90 $8,000

Others Institutions Holding RETA

# of Institutions
5
Shares Held
62.7K
Call Options Held
0
Put Options Held
0
View Full List

About REATA PHARMACEUTICALS INC

RETA Quotes by TradingView
  • Ticker RETA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,583,200
  • Description
  • Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...
More about RETA
Track This Portfolio

Track Twin Tree Management, LP Portfolio

Follow Twin Tree Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Twin Tree Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email